Global Oral Sustained and Controlled Release Formulations Market Growth 2022-2028
The global market for Oral Sustained and Controlled Release Formulations is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Oral Sustained and Controlled Release Formulations market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Oral Sustained and Controlled Release Formulations market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Oral Sustained and Controlled Release Formulations market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Oral Sustained and Controlled Release Formulations market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Oral Sustained and Controlled Release Formulations players cover Humanwell Healthcare Co.,Ltd., Nanjing Yiheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., Qilu Pharmaceutical Co Ltd and Shanghai Pharmaceuticals Holding Co.,Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Oral Sustained and Controlled Release Formulations market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Oral Sustained and Controlled Release Formulations market, with both quantitative and qualitative data, to help readers understand how the Oral Sustained and Controlled Release Formulations market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Oral Sustained and Controlled Release Formulations market and forecasts the market size by Type (Skeleton Type, Membrane Controlled Type and Osmotic Pump Type), by Application (Cardiovascular System Drugs, Nervous System Drugs, Digestive System and Metabolism and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Oral Sustained and Controlled Release Formulations, Research Methodology, etc.
Chapter 2: Executive Summary, global Oral Sustained and Controlled Release Formulations market size (sales and revenue) and CAGR, Oral Sustained and Controlled Release Formulations market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Oral Sustained and Controlled Release Formulations sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Oral Sustained and Controlled Release Formulations sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Oral Sustained and Controlled Release Formulations market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Humanwell Healthcare Co.,Ltd., Nanjing Yiheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., Qilu Pharmaceutical Co Ltd, Shanghai Pharmaceuticals Holding Co.,Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., PKU HealthCare Corp.,Ltd., Overseas Pharmaceuticals, Ltd. and Novast Laboratories (China), LTD., etc.
Chapter 14: Research Findings and Conclusion
The APAC Oral Sustained and Controlled Release Formulations market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Oral Sustained and Controlled Release Formulations market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Oral Sustained and Controlled Release Formulations market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Oral Sustained and Controlled Release Formulations market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Oral Sustained and Controlled Release Formulations players cover Humanwell Healthcare Co.,Ltd., Nanjing Yiheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., Qilu Pharmaceutical Co Ltd and Shanghai Pharmaceuticals Holding Co.,Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Oral Sustained and Controlled Release Formulations market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Oral Sustained and Controlled Release Formulations market, with both quantitative and qualitative data, to help readers understand how the Oral Sustained and Controlled Release Formulations market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Oral Sustained and Controlled Release Formulations market and forecasts the market size by Type (Skeleton Type, Membrane Controlled Type and Osmotic Pump Type), by Application (Cardiovascular System Drugs, Nervous System Drugs, Digestive System and Metabolism and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Skeleton Type
- Membrane Controlled Type
- Osmotic Pump Type
- Cardiovascular System Drugs
- Nervous System Drugs
- Digestive System and Metabolism
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Humanwell Healthcare Co.,Ltd.
- Nanjing Yiheng Pharmaceutical Co., Ltd.
- Jiangsu Hengrui Pharmaceuticals Co.,ltd.
- Qilu Pharmaceutical Co Ltd
- Shanghai Pharmaceuticals Holding Co.,Ltd.
- Yangtze River Pharmaceutical (Group) Co., Ltd.
- PKU HealthCare Corp.,Ltd.
- Overseas Pharmaceuticals, Ltd.
- Novast Laboratories (China), LTD.
- Catalent
- AstraZeneca Plc
- Oakwood Labs
- Ascendia Pharma
- Colorcon
- Pfizer Inc.
- Mylan
- Sandoz
Chapter 1: Scope of Oral Sustained and Controlled Release Formulations, Research Methodology, etc.
Chapter 2: Executive Summary, global Oral Sustained and Controlled Release Formulations market size (sales and revenue) and CAGR, Oral Sustained and Controlled Release Formulations market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Oral Sustained and Controlled Release Formulations sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Oral Sustained and Controlled Release Formulations sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Oral Sustained and Controlled Release Formulations market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Humanwell Healthcare Co.,Ltd., Nanjing Yiheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., Qilu Pharmaceutical Co Ltd, Shanghai Pharmaceuticals Holding Co.,Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., PKU HealthCare Corp.,Ltd., Overseas Pharmaceuticals, Ltd. and Novast Laboratories (China), LTD., etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Sustained and Controlled Release Formulations Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oral Sustained and Controlled Release Formulations by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oral Sustained and Controlled Release Formulations by Country/Region, 2017, 2022 & 2028
2.2 Oral Sustained and Controlled Release Formulations Segment by Type
2.2.1 Skeleton Type
2.2.2 Membrane Controlled Type
2.2.3 Osmotic Pump Type
2.3 Oral Sustained and Controlled Release Formulations Sales by Type
2.3.1 Global Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
2.3.2 Global Oral Sustained and Controlled Release Formulations Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oral Sustained and Controlled Release Formulations Sale Price by Type (2017-2022)
2.4 Oral Sustained and Controlled Release Formulations Segment by Application
2.4.1 Cardiovascular System Drugs
2.4.2 Nervous System Drugs
2.4.3 Digestive System and Metabolism
2.4.4 Other
2.5 Oral Sustained and Controlled Release Formulations Sales by Application
2.5.1 Global Oral Sustained and Controlled Release Formulations Sale Market Share by Application (2017-2022)
2.5.2 Global Oral Sustained and Controlled Release Formulations Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oral Sustained and Controlled Release Formulations Sale Price by Application (2017-2022)
3 GLOBAL ORAL SUSTAINED AND CONTROLLED RELEASE FORMULATIONS BY COMPANY
3.1 Global Oral Sustained and Controlled Release Formulations Breakdown Data by Company
3.1.1 Global Oral Sustained and Controlled Release Formulations Annual Sales by Company (2020-2022)
3.1.2 Global Oral Sustained and Controlled Release Formulations Sales Market Share by Company (2020-2022)
3.2 Global Oral Sustained and Controlled Release Formulations Annual Revenue by Company (2020-2022)
3.2.1 Global Oral Sustained and Controlled Release Formulations Revenue by Company (2020-2022)
3.2.2 Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Company (2020-2022)
3.3 Global Oral Sustained and Controlled Release Formulations Sale Price by Company
3.4 Key Manufacturers Oral Sustained and Controlled Release Formulations Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Sustained and Controlled Release Formulations Product Location Distribution
3.4.2 Players Oral Sustained and Controlled Release Formulations Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ORAL SUSTAINED AND CONTROLLED RELEASE FORMULATIONS BY GEOGRAPHIC REGION
4.1 World Historic Oral Sustained and Controlled Release Formulations Market Size by Geographic Region (2017-2022)
4.1.1 Global Oral Sustained and Controlled Release Formulations Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oral Sustained and Controlled Release Formulations Annual Revenue by Geographic Region
4.2 World Historic Oral Sustained and Controlled Release Formulations Market Size by Country/Region (2017-2022)
4.2.1 Global Oral Sustained and Controlled Release Formulations Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oral Sustained and Controlled Release Formulations Annual Revenue by Country/Region
4.3 Americas Oral Sustained and Controlled Release Formulations Sales Growth
4.4 APAC Oral Sustained and Controlled Release Formulations Sales Growth
4.5 Europe Oral Sustained and Controlled Release Formulations Sales Growth
4.6 Middle East & Africa Oral Sustained and Controlled Release Formulations Sales Growth
5 AMERICAS
5.1 Americas Oral Sustained and Controlled Release Formulations Sales by Country
5.1.1 Americas Oral Sustained and Controlled Release Formulations Sales by Country (2017-2022)
5.1.2 Americas Oral Sustained and Controlled Release Formulations Revenue by Country (2017-2022)
5.2 Americas Oral Sustained and Controlled Release Formulations Sales by Type
5.3 Americas Oral Sustained and Controlled Release Formulations Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Sustained and Controlled Release Formulations Sales by Region
6.1.1 APAC Oral Sustained and Controlled Release Formulations Sales by Region (2017-2022)
6.1.2 APAC Oral Sustained and Controlled Release Formulations Revenue by Region (2017-2022)
6.2 APAC Oral Sustained and Controlled Release Formulations Sales by Type
6.3 APAC Oral Sustained and Controlled Release Formulations Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Sustained and Controlled Release Formulations by Country
7.1.1 Europe Oral Sustained and Controlled Release Formulations Sales by Country (2017-2022)
7.1.2 Europe Oral Sustained and Controlled Release Formulations Revenue by Country (2017-2022)
7.2 Europe Oral Sustained and Controlled Release Formulations Sales by Type
7.3 Europe Oral Sustained and Controlled Release Formulations Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Sustained and Controlled Release Formulations by Country
8.1.1 Middle East & Africa Oral Sustained and Controlled Release Formulations Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oral Sustained and Controlled Release Formulations Revenue by Country (2017-2022)
8.2 Middle East & Africa Oral Sustained and Controlled Release Formulations Sales by Type
8.3 Middle East & Africa Oral Sustained and Controlled Release Formulations Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Sustained and Controlled Release Formulations
10.3 Manufacturing Process Analysis of Oral Sustained and Controlled Release Formulations
10.4 Industry Chain Structure of Oral Sustained and Controlled Release Formulations
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Sustained and Controlled Release Formulations Distributors
11.3 Oral Sustained and Controlled Release Formulations Customer
12 WORLD FORECAST REVIEW FOR ORAL SUSTAINED AND CONTROLLED RELEASE FORMULATIONS BY GEOGRAPHIC REGION
12.1 Global Oral Sustained and Controlled Release Formulations Market Size Forecast by Region
12.1.1 Global Oral Sustained and Controlled Release Formulations Forecast by Region (2023-2028)
12.1.2 Global Oral Sustained and Controlled Release Formulations Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Sustained and Controlled Release Formulations Forecast by Type
12.7 Global Oral Sustained and Controlled Release Formulations Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Humanwell Healthcare Co.,Ltd.
13.1.1 Humanwell Healthcare Co.,Ltd. Company Information
13.1.2 Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Product Offered
13.1.3 Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Humanwell Healthcare Co.,Ltd. Main Business Overview
13.1.5 Humanwell Healthcare Co.,Ltd. Latest Developments
13.2 Nanjing Yiheng Pharmaceutical Co., Ltd.
13.2.1 Nanjing Yiheng Pharmaceutical Co., Ltd. Company Information
13.2.2 Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Product Offered
13.2.3 Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Nanjing Yiheng Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Nanjing Yiheng Pharmaceutical Co., Ltd. Latest Developments
13.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
13.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
13.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Product Offered
13.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business Overview
13.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
13.4 Qilu Pharmaceutical Co Ltd
13.4.1 Qilu Pharmaceutical Co Ltd Company Information
13.4.2 Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Product Offered
13.4.3 Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Qilu Pharmaceutical Co Ltd Main Business Overview
13.4.5 Qilu Pharmaceutical Co Ltd Latest Developments
13.5 Shanghai Pharmaceuticals Holding Co.,Ltd.
13.5.1 Shanghai Pharmaceuticals Holding Co.,Ltd. Company Information
13.5.2 Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Product Offered
13.5.3 Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Shanghai Pharmaceuticals Holding Co.,Ltd. Main Business Overview
13.5.5 Shanghai Pharmaceuticals Holding Co.,Ltd. Latest Developments
13.6 Yangtze River Pharmaceutical (Group) Co., Ltd.
13.6.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
13.6.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Product Offered
13.6.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business Overview
13.6.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
13.7 PKU HealthCare Corp.,Ltd.
13.7.1 PKU HealthCare Corp.,Ltd. Company Information
13.7.2 PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Product Offered
13.7.3 PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 PKU HealthCare Corp.,Ltd. Main Business Overview
13.7.5 PKU HealthCare Corp.,Ltd. Latest Developments
13.8 Overseas Pharmaceuticals, Ltd.
13.8.1 Overseas Pharmaceuticals, Ltd. Company Information
13.8.2 Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Product Offered
13.8.3 Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Overseas Pharmaceuticals, Ltd. Main Business Overview
13.8.5 Overseas Pharmaceuticals, Ltd. Latest Developments
13.9 Novast Laboratories (China), LTD.
13.9.1 Novast Laboratories (China), LTD. Company Information
13.9.2 Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Product Offered
13.9.3 Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Novast Laboratories (China), LTD. Main Business Overview
13.9.5 Novast Laboratories (China), LTD. Latest Developments
13.10 Catalent
13.10.1 Catalent Company Information
13.10.2 Catalent Oral Sustained and Controlled Release Formulations Product Offered
13.10.3 Catalent Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Catalent Main Business Overview
13.10.5 Catalent Latest Developments
13.11 AstraZeneca Plc
13.11.1 AstraZeneca Plc Company Information
13.11.2 AstraZeneca Plc Oral Sustained and Controlled Release Formulations Product Offered
13.11.3 AstraZeneca Plc Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 AstraZeneca Plc Main Business Overview
13.11.5 AstraZeneca Plc Latest Developments
13.12 Oakwood Labs
13.12.1 Oakwood Labs Company Information
13.12.2 Oakwood Labs Oral Sustained and Controlled Release Formulations Product Offered
13.12.3 Oakwood Labs Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Oakwood Labs Main Business Overview
13.12.5 Oakwood Labs Latest Developments
13.13 Ascendia Pharma
13.13.1 Ascendia Pharma Company Information
13.13.2 Ascendia Pharma Oral Sustained and Controlled Release Formulations Product Offered
13.13.3 Ascendia Pharma Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Ascendia Pharma Main Business Overview
13.13.5 Ascendia Pharma Latest Developments
13.14 Colorcon
13.14.1 Colorcon Company Information
13.14.2 Colorcon Oral Sustained and Controlled Release Formulations Product Offered
13.14.3 Colorcon Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Colorcon Main Business Overview
13.14.5 Colorcon Latest Developments
13.15 Pfizer Inc.
13.15.1 Pfizer Inc. Company Information
13.15.2 Pfizer Inc. Oral Sustained and Controlled Release Formulations Product Offered
13.15.3 Pfizer Inc. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Pfizer Inc. Main Business Overview
13.15.5 Pfizer Inc. Latest Developments
13.16 Mylan
13.16.1 Mylan Company Information
13.16.2 Mylan Oral Sustained and Controlled Release Formulations Product Offered
13.16.3 Mylan Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Mylan Main Business Overview
13.16.5 Mylan Latest Developments
13.17 Sandoz
13.17.1 Sandoz Company Information
13.17.2 Sandoz Oral Sustained and Controlled Release Formulations Product Offered
13.17.3 Sandoz Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Sandoz Main Business Overview
13.17.5 Sandoz Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Sustained and Controlled Release Formulations Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oral Sustained and Controlled Release Formulations by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oral Sustained and Controlled Release Formulations by Country/Region, 2017, 2022 & 2028
2.2 Oral Sustained and Controlled Release Formulations Segment by Type
2.2.1 Skeleton Type
2.2.2 Membrane Controlled Type
2.2.3 Osmotic Pump Type
2.3 Oral Sustained and Controlled Release Formulations Sales by Type
2.3.1 Global Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
2.3.2 Global Oral Sustained and Controlled Release Formulations Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oral Sustained and Controlled Release Formulations Sale Price by Type (2017-2022)
2.4 Oral Sustained and Controlled Release Formulations Segment by Application
2.4.1 Cardiovascular System Drugs
2.4.2 Nervous System Drugs
2.4.3 Digestive System and Metabolism
2.4.4 Other
2.5 Oral Sustained and Controlled Release Formulations Sales by Application
2.5.1 Global Oral Sustained and Controlled Release Formulations Sale Market Share by Application (2017-2022)
2.5.2 Global Oral Sustained and Controlled Release Formulations Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oral Sustained and Controlled Release Formulations Sale Price by Application (2017-2022)
3 GLOBAL ORAL SUSTAINED AND CONTROLLED RELEASE FORMULATIONS BY COMPANY
3.1 Global Oral Sustained and Controlled Release Formulations Breakdown Data by Company
3.1.1 Global Oral Sustained and Controlled Release Formulations Annual Sales by Company (2020-2022)
3.1.2 Global Oral Sustained and Controlled Release Formulations Sales Market Share by Company (2020-2022)
3.2 Global Oral Sustained and Controlled Release Formulations Annual Revenue by Company (2020-2022)
3.2.1 Global Oral Sustained and Controlled Release Formulations Revenue by Company (2020-2022)
3.2.2 Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Company (2020-2022)
3.3 Global Oral Sustained and Controlled Release Formulations Sale Price by Company
3.4 Key Manufacturers Oral Sustained and Controlled Release Formulations Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Sustained and Controlled Release Formulations Product Location Distribution
3.4.2 Players Oral Sustained and Controlled Release Formulations Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ORAL SUSTAINED AND CONTROLLED RELEASE FORMULATIONS BY GEOGRAPHIC REGION
4.1 World Historic Oral Sustained and Controlled Release Formulations Market Size by Geographic Region (2017-2022)
4.1.1 Global Oral Sustained and Controlled Release Formulations Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oral Sustained and Controlled Release Formulations Annual Revenue by Geographic Region
4.2 World Historic Oral Sustained and Controlled Release Formulations Market Size by Country/Region (2017-2022)
4.2.1 Global Oral Sustained and Controlled Release Formulations Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oral Sustained and Controlled Release Formulations Annual Revenue by Country/Region
4.3 Americas Oral Sustained and Controlled Release Formulations Sales Growth
4.4 APAC Oral Sustained and Controlled Release Formulations Sales Growth
4.5 Europe Oral Sustained and Controlled Release Formulations Sales Growth
4.6 Middle East & Africa Oral Sustained and Controlled Release Formulations Sales Growth
5 AMERICAS
5.1 Americas Oral Sustained and Controlled Release Formulations Sales by Country
5.1.1 Americas Oral Sustained and Controlled Release Formulations Sales by Country (2017-2022)
5.1.2 Americas Oral Sustained and Controlled Release Formulations Revenue by Country (2017-2022)
5.2 Americas Oral Sustained and Controlled Release Formulations Sales by Type
5.3 Americas Oral Sustained and Controlled Release Formulations Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Sustained and Controlled Release Formulations Sales by Region
6.1.1 APAC Oral Sustained and Controlled Release Formulations Sales by Region (2017-2022)
6.1.2 APAC Oral Sustained and Controlled Release Formulations Revenue by Region (2017-2022)
6.2 APAC Oral Sustained and Controlled Release Formulations Sales by Type
6.3 APAC Oral Sustained and Controlled Release Formulations Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Sustained and Controlled Release Formulations by Country
7.1.1 Europe Oral Sustained and Controlled Release Formulations Sales by Country (2017-2022)
7.1.2 Europe Oral Sustained and Controlled Release Formulations Revenue by Country (2017-2022)
7.2 Europe Oral Sustained and Controlled Release Formulations Sales by Type
7.3 Europe Oral Sustained and Controlled Release Formulations Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Sustained and Controlled Release Formulations by Country
8.1.1 Middle East & Africa Oral Sustained and Controlled Release Formulations Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oral Sustained and Controlled Release Formulations Revenue by Country (2017-2022)
8.2 Middle East & Africa Oral Sustained and Controlled Release Formulations Sales by Type
8.3 Middle East & Africa Oral Sustained and Controlled Release Formulations Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Sustained and Controlled Release Formulations
10.3 Manufacturing Process Analysis of Oral Sustained and Controlled Release Formulations
10.4 Industry Chain Structure of Oral Sustained and Controlled Release Formulations
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Sustained and Controlled Release Formulations Distributors
11.3 Oral Sustained and Controlled Release Formulations Customer
12 WORLD FORECAST REVIEW FOR ORAL SUSTAINED AND CONTROLLED RELEASE FORMULATIONS BY GEOGRAPHIC REGION
12.1 Global Oral Sustained and Controlled Release Formulations Market Size Forecast by Region
12.1.1 Global Oral Sustained and Controlled Release Formulations Forecast by Region (2023-2028)
12.1.2 Global Oral Sustained and Controlled Release Formulations Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Sustained and Controlled Release Formulations Forecast by Type
12.7 Global Oral Sustained and Controlled Release Formulations Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Humanwell Healthcare Co.,Ltd.
13.1.1 Humanwell Healthcare Co.,Ltd. Company Information
13.1.2 Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Product Offered
13.1.3 Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Humanwell Healthcare Co.,Ltd. Main Business Overview
13.1.5 Humanwell Healthcare Co.,Ltd. Latest Developments
13.2 Nanjing Yiheng Pharmaceutical Co., Ltd.
13.2.1 Nanjing Yiheng Pharmaceutical Co., Ltd. Company Information
13.2.2 Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Product Offered
13.2.3 Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Nanjing Yiheng Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Nanjing Yiheng Pharmaceutical Co., Ltd. Latest Developments
13.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
13.3.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
13.3.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Product Offered
13.3.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business Overview
13.3.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
13.4 Qilu Pharmaceutical Co Ltd
13.4.1 Qilu Pharmaceutical Co Ltd Company Information
13.4.2 Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Product Offered
13.4.3 Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Qilu Pharmaceutical Co Ltd Main Business Overview
13.4.5 Qilu Pharmaceutical Co Ltd Latest Developments
13.5 Shanghai Pharmaceuticals Holding Co.,Ltd.
13.5.1 Shanghai Pharmaceuticals Holding Co.,Ltd. Company Information
13.5.2 Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Product Offered
13.5.3 Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Shanghai Pharmaceuticals Holding Co.,Ltd. Main Business Overview
13.5.5 Shanghai Pharmaceuticals Holding Co.,Ltd. Latest Developments
13.6 Yangtze River Pharmaceutical (Group) Co., Ltd.
13.6.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
13.6.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Product Offered
13.6.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business Overview
13.6.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
13.7 PKU HealthCare Corp.,Ltd.
13.7.1 PKU HealthCare Corp.,Ltd. Company Information
13.7.2 PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Product Offered
13.7.3 PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 PKU HealthCare Corp.,Ltd. Main Business Overview
13.7.5 PKU HealthCare Corp.,Ltd. Latest Developments
13.8 Overseas Pharmaceuticals, Ltd.
13.8.1 Overseas Pharmaceuticals, Ltd. Company Information
13.8.2 Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Product Offered
13.8.3 Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Overseas Pharmaceuticals, Ltd. Main Business Overview
13.8.5 Overseas Pharmaceuticals, Ltd. Latest Developments
13.9 Novast Laboratories (China), LTD.
13.9.1 Novast Laboratories (China), LTD. Company Information
13.9.2 Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Product Offered
13.9.3 Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Novast Laboratories (China), LTD. Main Business Overview
13.9.5 Novast Laboratories (China), LTD. Latest Developments
13.10 Catalent
13.10.1 Catalent Company Information
13.10.2 Catalent Oral Sustained and Controlled Release Formulations Product Offered
13.10.3 Catalent Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Catalent Main Business Overview
13.10.5 Catalent Latest Developments
13.11 AstraZeneca Plc
13.11.1 AstraZeneca Plc Company Information
13.11.2 AstraZeneca Plc Oral Sustained and Controlled Release Formulations Product Offered
13.11.3 AstraZeneca Plc Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 AstraZeneca Plc Main Business Overview
13.11.5 AstraZeneca Plc Latest Developments
13.12 Oakwood Labs
13.12.1 Oakwood Labs Company Information
13.12.2 Oakwood Labs Oral Sustained and Controlled Release Formulations Product Offered
13.12.3 Oakwood Labs Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Oakwood Labs Main Business Overview
13.12.5 Oakwood Labs Latest Developments
13.13 Ascendia Pharma
13.13.1 Ascendia Pharma Company Information
13.13.2 Ascendia Pharma Oral Sustained and Controlled Release Formulations Product Offered
13.13.3 Ascendia Pharma Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Ascendia Pharma Main Business Overview
13.13.5 Ascendia Pharma Latest Developments
13.14 Colorcon
13.14.1 Colorcon Company Information
13.14.2 Colorcon Oral Sustained and Controlled Release Formulations Product Offered
13.14.3 Colorcon Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Colorcon Main Business Overview
13.14.5 Colorcon Latest Developments
13.15 Pfizer Inc.
13.15.1 Pfizer Inc. Company Information
13.15.2 Pfizer Inc. Oral Sustained and Controlled Release Formulations Product Offered
13.15.3 Pfizer Inc. Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Pfizer Inc. Main Business Overview
13.15.5 Pfizer Inc. Latest Developments
13.16 Mylan
13.16.1 Mylan Company Information
13.16.2 Mylan Oral Sustained and Controlled Release Formulations Product Offered
13.16.3 Mylan Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Mylan Main Business Overview
13.16.5 Mylan Latest Developments
13.17 Sandoz
13.17.1 Sandoz Company Information
13.17.2 Sandoz Oral Sustained and Controlled Release Formulations Product Offered
13.17.3 Sandoz Oral Sustained and Controlled Release Formulations Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Sandoz Main Business Overview
13.17.5 Sandoz Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oral Sustained and Controlled Release Formulations Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oral Sustained and Controlled Release Formulations Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Skeleton Type
Table 4. Major Players of Membrane Controlled Type
Table 5. Major Players of Osmotic Pump Type
Table 6. Global Oral Sustained and Controlled Release Formulations Sales by Type (2017-2022) & (K Units)
Table 7. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
Table 8. Global Oral Sustained and Controlled Release Formulations Revenue by Type (2017-2022) & ($ million)
Table 9. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Type (2017-2022)
Table 10. Global Oral Sustained and Controlled Release Formulations Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Oral Sustained and Controlled Release Formulations Sales by Application (2017-2022) & (K Units)
Table 12. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Table 13. Global Oral Sustained and Controlled Release Formulations Revenue by Application (2017-2022)
Table 14. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Application (2017-2022)
Table 15. Global Oral Sustained and Controlled Release Formulations Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Oral Sustained and Controlled Release Formulations Sales by Company (2020-2022) & (K Units)
Table 17. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Company (2020-2022)
Table 18. Global Oral Sustained and Controlled Release Formulations Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Company (2020-2022)
Table 20. Global Oral Sustained and Controlled Release Formulations Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Oral Sustained and Controlled Release Formulations Producing Area Distribution and Sales Area
Table 22. Players Oral Sustained and Controlled Release Formulations Products Offered
Table 23. Oral Sustained and Controlled Release Formulations Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Oral Sustained and Controlled Release Formulations Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Oral Sustained and Controlled Release Formulations Sales Market Share Geographic Region (2017-2022)
Table 28. Global Oral Sustained and Controlled Release Formulations Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Oral Sustained and Controlled Release Formulations Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Country/Region (2017-2022)
Table 32. Global Oral Sustained and Controlled Release Formulations Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Oral Sustained and Controlled Release Formulations Sales by Country (2017-2022) & (K Units)
Table 35. Americas Oral Sustained and Controlled Release Formulations Sales Market Share by Country (2017-2022)
Table 36. Americas Oral Sustained and Controlled Release Formulations Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Oral Sustained and Controlled Release Formulations Revenue Market Share by Country (2017-2022)
Table 38. Americas Oral Sustained and Controlled Release Formulations Sales by Type (2017-2022) & (K Units)
Table 39. Americas Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
Table 40. Americas Oral Sustained and Controlled Release Formulations Sales by Application (2017-2022) & (K Units)
Table 41. Americas Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Table 42. APAC Oral Sustained and Controlled Release Formulations Sales by Region (2017-2022) & (K Units)
Table 43. APAC Oral Sustained and Controlled Release Formulations Sales Market Share by Region (2017-2022)
Table 44. APAC Oral Sustained and Controlled Release Formulations Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Oral Sustained and Controlled Release Formulations Revenue Market Share by Region (2017-2022)
Table 46. APAC Oral Sustained and Controlled Release Formulations Sales by Type (2017-2022) & (K Units)
Table 47. APAC Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
Table 48. APAC Oral Sustained and Controlled Release Formulations Sales by Application (2017-2022) & (K Units)
Table 49. APAC Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Table 50. Europe Oral Sustained and Controlled Release Formulations Sales by Country (2017-2022) & (K Units)
Table 51. Europe Oral Sustained and Controlled Release Formulations Sales Market Share by Country (2017-2022)
Table 52. Europe Oral Sustained and Controlled Release Formulations Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Oral Sustained and Controlled Release Formulations Revenue Market Share by Country (2017-2022)
Table 54. Europe Oral Sustained and Controlled Release Formulations Sales by Type (2017-2022) & (K Units)
Table 55. Europe Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
Table 56. Europe Oral Sustained and Controlled Release Formulations Sales by Application (2017-2022) & (K Units)
Table 57. Europe Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Oral Sustained and Controlled Release Formulations Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Oral Sustained and Controlled Release Formulations Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Oral Sustained and Controlled Release Formulations
Table 67. Key Market Challenges & Risks of Oral Sustained and Controlled Release Formulations
Table 68. Key Industry Trends of Oral Sustained and Controlled Release Formulations
Table 69. Oral Sustained and Controlled Release Formulations Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Oral Sustained and Controlled Release Formulations Distributors List
Table 72. Oral Sustained and Controlled Release Formulations Customer List
Table 73. Global Oral Sustained and Controlled Release Formulations Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Oral Sustained and Controlled Release Formulations Sales Market Forecast by Region
Table 75. Global Oral Sustained and Controlled Release Formulations Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Oral Sustained and Controlled Release Formulations Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Oral Sustained and Controlled Release Formulations Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Oral Sustained and Controlled Release Formulations Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Oral Sustained and Controlled Release Formulations Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Oral Sustained and Controlled Release Formulations Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Oral Sustained and Controlled Release Formulations Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Oral Sustained and Controlled Release Formulations Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Oral Sustained and Controlled Release Formulations Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Oral Sustained and Controlled Release Formulations Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Oral Sustained and Controlled Release Formulations Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Oral Sustained and Controlled Release Formulations Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Oral Sustained and Controlled Release Formulations Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Oral Sustained and Controlled Release Formulations Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Oral Sustained and Controlled Release Formulations Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Oral Sustained and Controlled Release Formulations Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Oral Sustained and Controlled Release Formulations Revenue Market Share Forecast by Application (2023-2028)
Table 93. Humanwell Healthcare Co.,Ltd. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 94. Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Product Offered
Table 95. Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Humanwell Healthcare Co.,Ltd. Main Business
Table 97. Humanwell Healthcare Co.,Ltd. Latest Developments
Table 98. Nanjing Yiheng Pharmaceutical Co., Ltd. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 99. Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Product Offered
Table 100. Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Nanjing Yiheng Pharmaceutical Co., Ltd. Main Business
Table 102. Nanjing Yiheng Pharmaceutical Co., Ltd. Latest Developments
Table 103. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 104. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Product Offered
Table 105. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business
Table 107. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
Table 108. Qilu Pharmaceutical Co Ltd Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 109. Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Product Offered
Table 110. Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Qilu Pharmaceutical Co Ltd Main Business
Table 112. Qilu Pharmaceutical Co Ltd Latest Developments
Table 113. Shanghai Pharmaceuticals Holding Co.,Ltd. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 114. Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Product Offered
Table 115. Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Shanghai Pharmaceuticals Holding Co.,Ltd. Main Business
Table 117. Shanghai Pharmaceuticals Holding Co.,Ltd. Latest Developments
Table 118. Yangtze River Pharmaceutical (Group) Co., Ltd. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 119. Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Product Offered
Table 120. Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business
Table 122. Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
Table 123. PKU HealthCare Corp.,Ltd. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 124. PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Product Offered
Table 125. PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. PKU HealthCare Corp.,Ltd. Main Business
Table 127. PKU HealthCare Corp.,Ltd. Latest Developments
Table 128. Overseas Pharmaceuticals, Ltd. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 129. Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Product Offered
Table 130. Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Overseas Pharmaceuticals, Ltd. Main Business
Table 132. Overseas Pharmaceuticals, Ltd. Latest Developments
Table 133. Novast Laboratories (China), LTD. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 134. Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Product Offered
Table 135. Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Novast Laboratories (China), LTD. Main Business
Table 137. Novast Laboratories (China), LTD. Latest Developments
Table 138. Catalent Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 139. Catalent Oral Sustained and Controlled Release Formulations Product Offered
Table 140. Catalent Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Catalent Main Business
Table 142. Catalent Latest Developments
Table 143. AstraZeneca Plc Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 144. AstraZeneca Plc Oral Sustained and Controlled Release Formulations Product Offered
Table 145. AstraZeneca Plc Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. AstraZeneca Plc Main Business
Table 147. AstraZeneca Plc Latest Developments
Table 148. Oakwood Labs Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 149. Oakwood Labs Oral Sustained and Controlled Release Formulations Product Offered
Table 150. Oakwood Labs Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Oakwood Labs Main Business
Table 152. Oakwood Labs Latest Developments
Table 153. Ascendia Pharma Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 154. Ascendia Pharma Oral Sustained and Controlled Release Formulations Product Offered
Table 155. Ascendia Pharma Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Ascendia Pharma Main Business
Table 157. Ascendia Pharma Latest Developments
Table 158. Colorcon Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 159. Colorcon Oral Sustained and Controlled Release Formulations Product Offered
Table 160. Colorcon Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Colorcon Main Business
Table 162. Colorcon Latest Developments
Table 163. Pfizer Inc. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 164. Pfizer Inc. Oral Sustained and Controlled Release Formulations Product Offered
Table 165. Pfizer Inc. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Pfizer Inc. Main Business
Table 167. Pfizer Inc. Latest Developments
Table 168. Mylan Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 169. Mylan Oral Sustained and Controlled Release Formulations Product Offered
Table 170. Mylan Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 171. Mylan Main Business
Table 172. Mylan Latest Developments
Table 173. Sandoz Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 174. Sandoz Oral Sustained and Controlled Release Formulations Product Offered
Table 175. Sandoz Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 176. Sandoz Main Business
Table 177. Sandoz Latest Developments
Table 1. Oral Sustained and Controlled Release Formulations Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oral Sustained and Controlled Release Formulations Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Skeleton Type
Table 4. Major Players of Membrane Controlled Type
Table 5. Major Players of Osmotic Pump Type
Table 6. Global Oral Sustained and Controlled Release Formulations Sales by Type (2017-2022) & (K Units)
Table 7. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
Table 8. Global Oral Sustained and Controlled Release Formulations Revenue by Type (2017-2022) & ($ million)
Table 9. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Type (2017-2022)
Table 10. Global Oral Sustained and Controlled Release Formulations Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Oral Sustained and Controlled Release Formulations Sales by Application (2017-2022) & (K Units)
Table 12. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Table 13. Global Oral Sustained and Controlled Release Formulations Revenue by Application (2017-2022)
Table 14. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Application (2017-2022)
Table 15. Global Oral Sustained and Controlled Release Formulations Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Oral Sustained and Controlled Release Formulations Sales by Company (2020-2022) & (K Units)
Table 17. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Company (2020-2022)
Table 18. Global Oral Sustained and Controlled Release Formulations Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Company (2020-2022)
Table 20. Global Oral Sustained and Controlled Release Formulations Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Oral Sustained and Controlled Release Formulations Producing Area Distribution and Sales Area
Table 22. Players Oral Sustained and Controlled Release Formulations Products Offered
Table 23. Oral Sustained and Controlled Release Formulations Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Oral Sustained and Controlled Release Formulations Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Oral Sustained and Controlled Release Formulations Sales Market Share Geographic Region (2017-2022)
Table 28. Global Oral Sustained and Controlled Release Formulations Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Oral Sustained and Controlled Release Formulations Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Country/Region (2017-2022)
Table 32. Global Oral Sustained and Controlled Release Formulations Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Oral Sustained and Controlled Release Formulations Sales by Country (2017-2022) & (K Units)
Table 35. Americas Oral Sustained and Controlled Release Formulations Sales Market Share by Country (2017-2022)
Table 36. Americas Oral Sustained and Controlled Release Formulations Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Oral Sustained and Controlled Release Formulations Revenue Market Share by Country (2017-2022)
Table 38. Americas Oral Sustained and Controlled Release Formulations Sales by Type (2017-2022) & (K Units)
Table 39. Americas Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
Table 40. Americas Oral Sustained and Controlled Release Formulations Sales by Application (2017-2022) & (K Units)
Table 41. Americas Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Table 42. APAC Oral Sustained and Controlled Release Formulations Sales by Region (2017-2022) & (K Units)
Table 43. APAC Oral Sustained and Controlled Release Formulations Sales Market Share by Region (2017-2022)
Table 44. APAC Oral Sustained and Controlled Release Formulations Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Oral Sustained and Controlled Release Formulations Revenue Market Share by Region (2017-2022)
Table 46. APAC Oral Sustained and Controlled Release Formulations Sales by Type (2017-2022) & (K Units)
Table 47. APAC Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
Table 48. APAC Oral Sustained and Controlled Release Formulations Sales by Application (2017-2022) & (K Units)
Table 49. APAC Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Table 50. Europe Oral Sustained and Controlled Release Formulations Sales by Country (2017-2022) & (K Units)
Table 51. Europe Oral Sustained and Controlled Release Formulations Sales Market Share by Country (2017-2022)
Table 52. Europe Oral Sustained and Controlled Release Formulations Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Oral Sustained and Controlled Release Formulations Revenue Market Share by Country (2017-2022)
Table 54. Europe Oral Sustained and Controlled Release Formulations Sales by Type (2017-2022) & (K Units)
Table 55. Europe Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
Table 56. Europe Oral Sustained and Controlled Release Formulations Sales by Application (2017-2022) & (K Units)
Table 57. Europe Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Oral Sustained and Controlled Release Formulations Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Oral Sustained and Controlled Release Formulations Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Oral Sustained and Controlled Release Formulations
Table 67. Key Market Challenges & Risks of Oral Sustained and Controlled Release Formulations
Table 68. Key Industry Trends of Oral Sustained and Controlled Release Formulations
Table 69. Oral Sustained and Controlled Release Formulations Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Oral Sustained and Controlled Release Formulations Distributors List
Table 72. Oral Sustained and Controlled Release Formulations Customer List
Table 73. Global Oral Sustained and Controlled Release Formulations Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Oral Sustained and Controlled Release Formulations Sales Market Forecast by Region
Table 75. Global Oral Sustained and Controlled Release Formulations Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Oral Sustained and Controlled Release Formulations Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Oral Sustained and Controlled Release Formulations Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Oral Sustained and Controlled Release Formulations Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Oral Sustained and Controlled Release Formulations Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Oral Sustained and Controlled Release Formulations Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Oral Sustained and Controlled Release Formulations Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Oral Sustained and Controlled Release Formulations Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Oral Sustained and Controlled Release Formulations Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Oral Sustained and Controlled Release Formulations Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Oral Sustained and Controlled Release Formulations Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Oral Sustained and Controlled Release Formulations Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Oral Sustained and Controlled Release Formulations Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Oral Sustained and Controlled Release Formulations Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Oral Sustained and Controlled Release Formulations Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Oral Sustained and Controlled Release Formulations Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Oral Sustained and Controlled Release Formulations Revenue Market Share Forecast by Application (2023-2028)
Table 93. Humanwell Healthcare Co.,Ltd. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 94. Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Product Offered
Table 95. Humanwell Healthcare Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Humanwell Healthcare Co.,Ltd. Main Business
Table 97. Humanwell Healthcare Co.,Ltd. Latest Developments
Table 98. Nanjing Yiheng Pharmaceutical Co., Ltd. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 99. Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Product Offered
Table 100. Nanjing Yiheng Pharmaceutical Co., Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Nanjing Yiheng Pharmaceutical Co., Ltd. Main Business
Table 102. Nanjing Yiheng Pharmaceutical Co., Ltd. Latest Developments
Table 103. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 104. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Product Offered
Table 105. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business
Table 107. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
Table 108. Qilu Pharmaceutical Co Ltd Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 109. Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Product Offered
Table 110. Qilu Pharmaceutical Co Ltd Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Qilu Pharmaceutical Co Ltd Main Business
Table 112. Qilu Pharmaceutical Co Ltd Latest Developments
Table 113. Shanghai Pharmaceuticals Holding Co.,Ltd. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 114. Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Product Offered
Table 115. Shanghai Pharmaceuticals Holding Co.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Shanghai Pharmaceuticals Holding Co.,Ltd. Main Business
Table 117. Shanghai Pharmaceuticals Holding Co.,Ltd. Latest Developments
Table 118. Yangtze River Pharmaceutical (Group) Co., Ltd. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 119. Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Product Offered
Table 120. Yangtze River Pharmaceutical (Group) Co., Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business
Table 122. Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
Table 123. PKU HealthCare Corp.,Ltd. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 124. PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Product Offered
Table 125. PKU HealthCare Corp.,Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. PKU HealthCare Corp.,Ltd. Main Business
Table 127. PKU HealthCare Corp.,Ltd. Latest Developments
Table 128. Overseas Pharmaceuticals, Ltd. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 129. Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Product Offered
Table 130. Overseas Pharmaceuticals, Ltd. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Overseas Pharmaceuticals, Ltd. Main Business
Table 132. Overseas Pharmaceuticals, Ltd. Latest Developments
Table 133. Novast Laboratories (China), LTD. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 134. Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Product Offered
Table 135. Novast Laboratories (China), LTD. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Novast Laboratories (China), LTD. Main Business
Table 137. Novast Laboratories (China), LTD. Latest Developments
Table 138. Catalent Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 139. Catalent Oral Sustained and Controlled Release Formulations Product Offered
Table 140. Catalent Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Catalent Main Business
Table 142. Catalent Latest Developments
Table 143. AstraZeneca Plc Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 144. AstraZeneca Plc Oral Sustained and Controlled Release Formulations Product Offered
Table 145. AstraZeneca Plc Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. AstraZeneca Plc Main Business
Table 147. AstraZeneca Plc Latest Developments
Table 148. Oakwood Labs Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 149. Oakwood Labs Oral Sustained and Controlled Release Formulations Product Offered
Table 150. Oakwood Labs Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Oakwood Labs Main Business
Table 152. Oakwood Labs Latest Developments
Table 153. Ascendia Pharma Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 154. Ascendia Pharma Oral Sustained and Controlled Release Formulations Product Offered
Table 155. Ascendia Pharma Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Ascendia Pharma Main Business
Table 157. Ascendia Pharma Latest Developments
Table 158. Colorcon Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 159. Colorcon Oral Sustained and Controlled Release Formulations Product Offered
Table 160. Colorcon Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Colorcon Main Business
Table 162. Colorcon Latest Developments
Table 163. Pfizer Inc. Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 164. Pfizer Inc. Oral Sustained and Controlled Release Formulations Product Offered
Table 165. Pfizer Inc. Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Pfizer Inc. Main Business
Table 167. Pfizer Inc. Latest Developments
Table 168. Mylan Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 169. Mylan Oral Sustained and Controlled Release Formulations Product Offered
Table 170. Mylan Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 171. Mylan Main Business
Table 172. Mylan Latest Developments
Table 173. Sandoz Basic Information, Oral Sustained and Controlled Release Formulations Manufacturing Base, Sales Area and Its Competitors
Table 174. Sandoz Oral Sustained and Controlled Release Formulations Product Offered
Table 175. Sandoz Oral Sustained and Controlled Release Formulations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 176. Sandoz Main Business
Table 177. Sandoz Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oral Sustained and Controlled Release Formulations
Figure 2. Oral Sustained and Controlled Release Formulations Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Sustained and Controlled Release Formulations Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Oral Sustained and Controlled Release Formulations Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oral Sustained and Controlled Release Formulations Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Skeleton Type
Figure 10. Product Picture of Membrane Controlled Type
Figure 11. Product Picture of Osmotic Pump Type
Figure 12. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Type in 2021
Figure 13. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Type (2017-2022)
Figure 14. Oral Sustained and Controlled Release Formulations Consumed in Cardiovascular System Drugs
Figure 15. Global Oral Sustained and Controlled Release Formulations Market: Cardiovascular System Drugs (2017-2022) & (K Units)
Figure 16. Oral Sustained and Controlled Release Formulations Consumed in Nervous System Drugs
Figure 17. Global Oral Sustained and Controlled Release Formulations Market: Nervous System Drugs (2017-2022) & (K Units)
Figure 18. Oral Sustained and Controlled Release Formulations Consumed in Digestive System and Metabolism
Figure 19. Global Oral Sustained and Controlled Release Formulations Market: Digestive System and Metabolism (2017-2022) & (K Units)
Figure 20. Oral Sustained and Controlled Release Formulations Consumed in Other
Figure 21. Global Oral Sustained and Controlled Release Formulations Market: Other (2017-2022) & (K Units)
Figure 22. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Figure 23. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Application in 2021
Figure 24. Oral Sustained and Controlled Release Formulations Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Company in 2021
Figure 26. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Geographic Region in 2021
Figure 28. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Region (2017-2022)
Figure 29. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Country/Region in 2021
Figure 30. Americas Oral Sustained and Controlled Release Formulations Sales 2017-2022 (K Units)
Figure 31. Americas Oral Sustained and Controlled Release Formulations Revenue 2017-2022 ($ Millions)
Figure 32. APAC Oral Sustained and Controlled Release Formulations Sales 2017-2022 (K Units)
Figure 33. APAC Oral Sustained and Controlled Release Formulations Revenue 2017-2022 ($ Millions)
Figure 34. Europe Oral Sustained and Controlled Release Formulations Sales 2017-2022 (K Units)
Figure 35. Europe Oral Sustained and Controlled Release Formulations Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Oral Sustained and Controlled Release Formulations Revenue 2017-2022 ($ Millions)
Figure 38. Americas Oral Sustained and Controlled Release Formulations Sales Market Share by Country in 2021
Figure 39. Americas Oral Sustained and Controlled Release Formulations Revenue Market Share by Country in 2021
Figure 40. United States Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Oral Sustained and Controlled Release Formulations Sales Market Share by Region in 2021
Figure 45. APAC Oral Sustained and Controlled Release Formulations Revenue Market Share by Regions in 2021
Figure 46. China Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Oral Sustained and Controlled Release Formulations Sales Market Share by Country in 2021
Figure 53. Europe Oral Sustained and Controlled Release Formulations Revenue Market Share by Country in 2021
Figure 54. Germany Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Oral Sustained and Controlled Release Formulations Revenue Market Share by Country in 2021
Figure 61. Egypt Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Oral Sustained and Controlled Release Formulations in 2021
Figure 67. Manufacturing Process Analysis of Oral Sustained and Controlled Release Formulations
Figure 68. Industry Chain Structure of Oral Sustained and Controlled Release Formulations
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 1. Picture of Oral Sustained and Controlled Release Formulations
Figure 2. Oral Sustained and Controlled Release Formulations Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Sustained and Controlled Release Formulations Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Oral Sustained and Controlled Release Formulations Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oral Sustained and Controlled Release Formulations Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Skeleton Type
Figure 10. Product Picture of Membrane Controlled Type
Figure 11. Product Picture of Osmotic Pump Type
Figure 12. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Type in 2021
Figure 13. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Type (2017-2022)
Figure 14. Oral Sustained and Controlled Release Formulations Consumed in Cardiovascular System Drugs
Figure 15. Global Oral Sustained and Controlled Release Formulations Market: Cardiovascular System Drugs (2017-2022) & (K Units)
Figure 16. Oral Sustained and Controlled Release Formulations Consumed in Nervous System Drugs
Figure 17. Global Oral Sustained and Controlled Release Formulations Market: Nervous System Drugs (2017-2022) & (K Units)
Figure 18. Oral Sustained and Controlled Release Formulations Consumed in Digestive System and Metabolism
Figure 19. Global Oral Sustained and Controlled Release Formulations Market: Digestive System and Metabolism (2017-2022) & (K Units)
Figure 20. Oral Sustained and Controlled Release Formulations Consumed in Other
Figure 21. Global Oral Sustained and Controlled Release Formulations Market: Other (2017-2022) & (K Units)
Figure 22. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Application (2017-2022)
Figure 23. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Application in 2021
Figure 24. Oral Sustained and Controlled Release Formulations Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Company in 2021
Figure 26. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Geographic Region in 2021
Figure 28. Global Oral Sustained and Controlled Release Formulations Sales Market Share by Region (2017-2022)
Figure 29. Global Oral Sustained and Controlled Release Formulations Revenue Market Share by Country/Region in 2021
Figure 30. Americas Oral Sustained and Controlled Release Formulations Sales 2017-2022 (K Units)
Figure 31. Americas Oral Sustained and Controlled Release Formulations Revenue 2017-2022 ($ Millions)
Figure 32. APAC Oral Sustained and Controlled Release Formulations Sales 2017-2022 (K Units)
Figure 33. APAC Oral Sustained and Controlled Release Formulations Revenue 2017-2022 ($ Millions)
Figure 34. Europe Oral Sustained and Controlled Release Formulations Sales 2017-2022 (K Units)
Figure 35. Europe Oral Sustained and Controlled Release Formulations Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Oral Sustained and Controlled Release Formulations Revenue 2017-2022 ($ Millions)
Figure 38. Americas Oral Sustained and Controlled Release Formulations Sales Market Share by Country in 2021
Figure 39. Americas Oral Sustained and Controlled Release Formulations Revenue Market Share by Country in 2021
Figure 40. United States Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Oral Sustained and Controlled Release Formulations Sales Market Share by Region in 2021
Figure 45. APAC Oral Sustained and Controlled Release Formulations Revenue Market Share by Regions in 2021
Figure 46. China Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Oral Sustained and Controlled Release Formulations Sales Market Share by Country in 2021
Figure 53. Europe Oral Sustained and Controlled Release Formulations Revenue Market Share by Country in 2021
Figure 54. Germany Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Oral Sustained and Controlled Release Formulations Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Oral Sustained and Controlled Release Formulations Revenue Market Share by Country in 2021
Figure 61. Egypt Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Oral Sustained and Controlled Release Formulations Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Oral Sustained and Controlled Release Formulations in 2021
Figure 67. Manufacturing Process Analysis of Oral Sustained and Controlled Release Formulations
Figure 68. Industry Chain Structure of Oral Sustained and Controlled Release Formulations
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
